Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > Aphria # 1 in Canada with A1 & DD Just Getting Started
View:
Post by Savage97 on Sep 14, 2020 4:29pm

Aphria # 1 in Canada with A1 & DD Just Getting Started

Positive EBITDA gives a sense of how well a company is handling its operating expenses, Aphria reported EBITDA of CA$8.6 million, a stunning 49% increase from CA$5.7 million in the year-ago quarter. Aurora and Canopy have yet to achieve profitability and are not even close yet.  Aphria has an upper hand in sales, with fiscal 2020 revenue coming in at $543.3 million Canadian dollars, a year-over-year increase of 129%.  Aphria's net revenue was up 18% from the year-ago quarter to CA$152 million, with CA$65.4 million coming from cannabis products and CA$99.1 million from distribution revenue. Irwin's strategy of focusing Aphria on its core operations in Canada has played out well.  Aphria was the first company to launch a variety of vape products in Canada which have generated great sales.  In contrast, Aurora and Canopy Growth's misteps proved unprofitable.  Aphria has already created a stronghold with its medical and recreational cannabis operations in Canada, with Germany, Italy, Malta, Colombia, and Argentina to follow.  Its cash position remains robust, with CA$497.2 million of cash and cash equivalents on the books in the recent quarter to fuel its expansion plans in Canada and internationally.

Comment by Sid123 on Sep 14, 2020 5:04pm
Totally agree I've consolidated most of my holdings into APHA as they have clearly seperated themselves from the pack. Can't wait for tomorrow getting huge selection of vapes for my stores from Riff & Good Supply. Have not really talked about Subway Scientist PR from Riff but thc coming in between 26-29% they sell out within a day or two.  Aurora with its disaster balance sheet ...more  
Comment by mlcb2525 on Sep 15, 2020 1:01am
Will you stop repeating yourself..................
Comment by Savage97 on Sep 15, 2020 7:07am
LOL.  Music to my ears every time a member from the poser clown crew gets butt hurt lol.  Use the ignore button if you don't like my posts.  GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities